← All trials
NCT06541444
Early Phase 1Interventional
Exploratory trials, involving very limited human exposure, with no therapeutic or diagnostic intent (e.g., screening studies, microdose studies).
View on ClinicalTrials.gov ↗Timeline
- Start date
- Jul 1, 2024
- Primary completion
- Jun 1, 2026
- Completion date
- Jun 1, 2026
- First posted
- Aug 7, 2024
- Last posted
- Aug 7, 2024
- Enrollment
- 9
- Arms / groups
- 3 / —
- Source
- AACT · ctgov ingestion
Sponsors
- Base Therapeutics (Shanghai) Co., Ltd.Lead sponsor
- Ningxia Medical UniversityOfficial
- Ningxia Medical UniversityCollaborator
Drugs studied
Indications studied
CDEK-curated fields only — the ClinicalTrials.gov results mirror (baseline measures, adverse events, participant flow) is a separate, currently-dormant pipeline; see MIGRATION_PLAN.md.